Remdesivir isn t a magic bullet : AIIMS chief on drug s use to treat Covid-19
Premium
(ANI)
Share Via
Read Full Story
As India reels under the massive surge of Covid-19 cases in the second wave of the pandemic, the All India Institute of Medical Sciences (AIIMS) Delhi director Dr Randeep Guleria highlighted some pertinent points of Covid management in the country.
In an interview, AIIMS chief spoke at length about the treatment of Covid-19 through drugs, steroids and CT scans.
TRENDING STORIESSee All
3 min read
Premium
2 min read
Premium
1 min read
Premium
1 min read
. 08:41 AM IST
Highlighting the usage of the anti-viral drug Remdesivir, Guleria informed, It s important to understand that Remdesivir isn t magic bullet and isn t a drug that decreases mortality. We may use it as we don t have an anti-viral drug. It s of no use if given early to asymptomatic individuals/ones with mild symptoms. Also of no use, if given late, according to news agency
Updated Apr 12, 2021 | 17:27 IST
AIIMS Director Dr Randeep Guleria said the rate of spread of the Covid-19 infection is fast this time possibly due to the highly infectious and transmissible strains that are circulating. AIIMS Director Dr Randeep Guleria | Photo Credit: ANI
Key Highlights
Dr Randeep Guleria calls for stricter enforcement of Covid guidelines
He also urges the people to get vaccinated against Covid-19
New Delhi: AIIMS Director Dr Randeep Guleria on Monday expressed concern over the fact that people had started to take Covid-19 lightly when highly infectious and transmissible strains of the coronavirus are circulating in the country. He said if the people fail to follow Covid-19 guidelines, the situation may get out of control.
PM Modi s move to get inoculated would instil confidence among people, remove hesitancy: AIIMS chief
India
Published: Monday, March 1, 2021, 13:02 [IST]
New Delhi, Mar 01: Prime Minister Narendra Modi s move to take the first dose of COVID-19 vaccine on the very first day of India opening up the inoculation drive for senior citizens and those aged 45 and above with comorbidities should eliminate any hesitancy from the minds of people about the vaccine, AIIMS chief Dr Randeep Guleria said on Monday.
PM Modi chats with AIIMS nurses | What did he say | Oneindia News
Modi received the indigenously developed Covaxin jab by Bharat Biotech on Monday morning.